Lilly tops IDEA Pharma’s 10th annual Pharmaceutical Innovation IndexAstraZeneca, Big Pharma, Bristol Myers Squibb, Business, Eli Lilly, GlaxoSmithKline, Incyte, Innovation, Johnson & Johnson, Merck, Novartis, Pfizer, Product Pipelines, R&D, Rankings, Regeneron Pharmaceuticals, Roche, SanofiThe tenth annual Pharmaceutical Innovation Index, released April 21, sees Eli Lilly top the industry for the first time. The Pharmaceutical Invention Index, a ranking of the industry’s best pipelines, rated Bristol Myers Squibb as No. 1. Read more April 21, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/04/Celebrating_Innovation_2021_Pharmaceutical_Innovation_Index.jpg 922 1088 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-04-21 11:08:292021-04-21 12:49:30Lilly tops IDEA Pharma’s 10th annual Pharmaceutical Innovation Index